Drug rebate agreements under open-house procedure
Original notice title
Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Buyer
Name
IKK classic
Location
Dresden, DEU
Identifier
993-80175-34
Activity
Health
Lots (53)
LOT-0001
Amoxicillin; ATC-Code: J01CA04
Amoxicillin; ATC-Code: J01CA04
Location
Duration
Category
Award details
Selection criteria
LOT-0002
Amoxicillin und Clavulansäure; ATC-Code: J01CR02
Amoxicillin und Clavulansäure; ATC-Code: J01CR02
Location
Duration
Category
Award details
Selection criteria
LOT-0003
Apremilast; ATC-Code: L04AA32
Apremilast; ATC-Code: L04AA32
Location
Duration
Category
Award details
Selection criteria
LOT-0004
Azithromycin; ATC-Code: J01FA10
Azithromycin; ATC-Code: J01FA10
Location
Duration
Category
Award details
Selection criteria
LOT-0005
Belimumab; ATC-Code:L04AG04
Belimumab; ATC-Code:L04AG04
Location
Duration
Category
Award details
Selection criteria
LOT-0006
Betamethason und Fusidinsäure; ATC-Code: D07CC01
Betamethason und Fusidinsäure; ATC-Code: D07CC01
Location
Duration
Category
Award details
Selection criteria
LOT-0007
Buprenorphin; Pflaster transdermal; Tragedauer 3 Tage; ATC-Code: N02AE01
Buprenorphin; Pflaster transdermal; Tragedauer 3 Tage; ATC-Code: N02AE01
Location
Duration
Category
Award details
Selection criteria
LOT-0008
Calciumcarbonat und Colecalciferol; ATC-Code: A12AX01 (ADV); A12AX (WHO)
Calciumcarbonat und Colecalciferol; ATC-Code: A12AX01 (ADV); A12AX (WHO)
Location
Duration
Category
Award details
Selection criteria
LOT-0009
Carbamazepin; Retardtabletten; ATC-Code: N03AF01
Carbamazepin; Retardtabletten; ATC-Code: N03AF01
Location
Duration
Category
Award details
Selection criteria
LOT-0010
Ceftriaxon; ATC-Code: J01DD04
Ceftriaxon; ATC-Code: J01DD04
Location
Duration
Category
Award details
Selection criteria
LOT-0011
Cefuroxim; ATC-Code: J01DC02
Cefuroxim; ATC-Code: J01DC02
Location
Duration
Category
Award details
Selection criteria
LOT-0012
Ciprofloxacin; ATC-Code: J01MA02
Ciprofloxacin; ATC-Code: J01MA02
Location
Duration
Category
Award details
Selection criteria
LOT-0013
Clindamycin; ATC-Code: J01FF01
Clindamycin; ATC-Code: J01FF01
Location
Duration
Category
Award details
Selection criteria
LOT-0014
Doravirin; ATC-Code: J05AG06
Doravirin; ATC-Code: J05AG06
Location
Duration
Category
Award details
Selection criteria
LOT-0015
Doxycyclin; ATC-Code: J01AA02
Doxycyclin; ATC-Code: J01AA02
Location
Duration
Category
Award details
Selection criteria
LOT-0016
Elbasvir und Grazoprevir; ATC-Code: J05AP54
Elbasvir und Grazoprevir; ATC-Code: J05AP54
Location
Duration
Category
Award details
Selection criteria
LOT-0017
Escitalopram; Tropfen zum Einnehmen; ATC-Code: N06AB10
Escitalopram; Tropfen zum Einnehmen; ATC-Code: N06AB10
Location
Duration
Category
Award details
Selection criteria
LOT-0018
Estradiol; Filmtabletten; ATC-Code: G03CA03
Estradiol; Filmtabletten; ATC-Code: G03CA03
Location
Duration
Category
Award details
Selection criteria
LOT-0019
Fentanyl; Pflaster transdermal; Wirkstoffmenge 4,8 mg, 9,6 mg, 14,4 mg und 19,2 mg; ATC-Code: N02AB03
Fentanyl; Pflaster transdermal; Wirkstoffmenge 4,8 mg, 9,6 mg, 14,4 mg und 19,2 mg; ATC-Code: N02AB03
Location
Duration
Category
Award details
Selection criteria
LOT-0020
Fesoterodin; ATC-Code: G04BD11
Fesoterodin; ATC-Code: G04BD11
Location
Duration
Category
Award details
Selection criteria
LOT-0021
Fosfomycin; ATC-Code: J01XX01
Fosfomycin; ATC-Code: J01XX01
Location
Duration
Category
Award details
Selection criteria
LOT-0022
Galsulfase; ATC-Code: A16AB08
Galsulfase; ATC-Code: A16AB08
Location
Duration
Category
Award details
Selection criteria
LOT-0023
Glyceroltrinitrat; Salbe; ATC-Code: C05AE01
Glyceroltrinitrat; Salbe; ATC-Code: C05AE01
Location
Duration
Category
Award details
Selection criteria
LOT-0024
Guanfacin; ATC-Code: N06BA21 (ADV); C02AC02 (WHO)
Guanfacin; ATC-Code: N06BA21 (ADV); C02AC02 (WHO)
Location
Duration
Category
Award details
Selection criteria
LOT-0025
Haloperidol; Injektionslösung; ATC-Code: N05AD01
Haloperidol; Injektionslösung; ATC-Code: N05AD01
Location
Duration
Category
Award details
Selection criteria
LOT-0026
Hydrochlorothiazid und Triamteren; ATC-Code: C03EA21 (ADV); C03EA01 (WHO)
Hydrochlorothiazid und Triamteren; ATC-Code: C03EA21 (ADV); C03EA01 (WHO)
Location
Duration
Category
Award details
Selection criteria
LOT-0027
Ipratropiumbromid; Dosieraerosol; ATC-Code: R03BB01
Ipratropiumbromid; Dosieraerosol; ATC-Code: R03BB01
Location
Duration
Category
Award details
Selection criteria
LOT-0028
Lactulose; Sirup; ATC-Code: A06AD11
Lactulose; Sirup; ATC-Code: A06AD11
Location
Duration
Category
Award details
Selection criteria
LOT-0029
Lamivudin, Tenofovirdisoproxil und Doravirin; ATC-Code: J05AR24
Lamivudin, Tenofovirdisoproxil und Doravirin; ATC-Code: J05AR24
Location
Duration
Category
Award details
Selection criteria
LOT-0030
Levodopa und Carbidopa; Retardtabletten; ATC-Code: N04BA10 (ADV); N04BA02 (WHO)
Levodopa und Carbidopa; Retardtabletten; ATC-Code: N04BA10 (ADV); N04BA02 (WHO)
Location
Duration
Category
Award details
Selection criteria
LOT-0031
Levothyroxin-Natrium; ATC-Code: H03AA01
Levothyroxin-Natrium; ATC-Code: H03AA01
Location
Duration
Category
Award details
Selection criteria
LOT-0032
Macrogol, Kombinationen; Pulver zur Herstellung einer Lösung zum Einnehmen; ATC-Code: A06AD65
Macrogol, Kombinationen; Pulver zur Herstellung einer Lösung zum Einnehmen; ATC-Code: A06AD65
Location
Duration
Category
Award details
Selection criteria
LOT-0033
Methyldopa (linksdrehend); ATC-Code: C02AB01
Methyldopa (linksdrehend); ATC-Code: C02AB01
Location
Duration
Category
Award details
Selection criteria
LOT-0034
Methylprednisolon; Pulver u. Lösungsm. z. Herst. e. Injektions- bzw. Infusionsl.; ATC-Code: H02AB04
Methylprednisolon; Pulver u. Lösungsm. z. Herst. e. Injektions- bzw. Infusionsl.; ATC-Code: H02AB04
Location
Duration
Category
Award details
Selection criteria
LOT-0035
Metronidazol; ATC-Code: P01AB01
Metronidazol; ATC-Code: P01AB01
Location
Duration
Category
Award details
Selection criteria
LOT-0036
Moxifloxacin; ATC-Code: J01MA14
Moxifloxacin; ATC-Code: J01MA14
Location
Duration
Category
Award details
Selection criteria
LOT-0037
Nifedipin; ATC-Code: C08CA05
Nifedipin; ATC-Code: C08CA05
Location
Duration
Category
Award details
Selection criteria
LOT-0038
Norethisteron und Estradiol; ATC-Code: G03FA01
Norethisteron und Estradiol; ATC-Code: G03FA01
Location
Duration
Category
Award details
Selection criteria
LOT-0039
Octreotid; ATC-Code: H01CB02
Octreotid; ATC-Code: H01CB02
Location
Duration
Category
Award details
Selection criteria
LOT-0040
Pamidronsäure; ATC-Code: M05BA03
Pamidronsäure; ATC-Code: M05BA03
Location
Duration
Category
Award details
Selection criteria
LOT-0041
Pazopanib; ATC-Code: L01EX03
Pazopanib; ATC-Code: L01EX03
Location
Duration
Category
Award details
Selection criteria
LOT-0042
Piracetam; Filmtabletten; ATC-Code: N06BX03
Piracetam; Filmtabletten; ATC-Code: N06BX03
Location
Duration
Category
Award details
Selection criteria
LOT-0043
Prednison; ATC-Code: H02AB07
Prednison; ATC-Code: H02AB07
Location
Duration
Category
Award details
Selection criteria
LOT-0044
Rabeprazol; ATC-Code: A02BC04
Rabeprazol; ATC-Code: A02BC04
Location
Duration
Category
Award details
Selection criteria
LOT-0045
Rivaroxaban; ohne Wirkstärke 2,5 mg; ATC-Code: B01AF01
Rivaroxaban; ohne Wirkstärke 2,5 mg; ATC-Code: B01AF01
Location
Duration
Category
Award details
Selection criteria
LOT-0046
Salbutamol und Ipratropiumbromid; ATC-Code: R03AL02
Salbutamol und Ipratropiumbromid; ATC-Code: R03AL02
Location
Duration
Category
Award details
Selection criteria
LOT-0047
Salmeterol; ATC-Code: R03AC12
Salmeterol; ATC-Code: R03AC12
Location
Duration
Category
Award details
Selection criteria
LOT-0048
Tacrolimus; Hartkapseln; ATC-Code: L04AD02
Tacrolimus; Hartkapseln; ATC-Code: L04AD02
Location
Duration
Category
Award details
Selection criteria
LOT-0049
Tobramycin; Lösung für einen Vernebler; ATC-Code: J01GB01
Tobramycin; Lösung für einen Vernebler; ATC-Code: J01GB01
Location
Duration
Category
Award details
Selection criteria
LOT-0050
Tolvaptan; Tabletten; Wirkstärke 7,5 mg und 30 mg; Packungsgröße 30 TAB; ATC-Code: C03XA01
Tolvaptan; Tabletten; Wirkstärke 7,5 mg und 30 mg; Packungsgröße 30 TAB; ATC-Code: C03XA01
Location
Duration
Category
Award details
Selection criteria
LOT-0051
Triamcinolon; ATC-Code: D07AB09
Triamcinolon; ATC-Code: D07AB09
Location
Duration
Category
Award details
Selection criteria
LOT-0052
Valproinsäure; Filmtabletten magensaftresistent; ATC-Code: N03AG01
Valproinsäure; Filmtabletten magensaftresistent; ATC-Code: N03AG01
Location
Duration
Category
Award details
Selection criteria
LOT-0053
Valproinsäure; Retardtabletten; ATC-Code: N03AG01
Valproinsäure; Retardtabletten; ATC-Code: N03AG01
Location
Duration
Category
Award details
Selection criteria
Procurement Details
- Publication date
- 16 Nov 2025
- Notice type
- Contract notice — standard
- Languages
- German
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 759734-2025
Documents (1)
Similar tenders
Germany – Heating, ventilation and air-conditioning installation work – VE BT11-4310-01 Lüftung
Belgium – Electrical supplies and accessories – Raamovereenkomst voor het leveren van verlichtingsarmaturen
Czechia – Vertical-spindle machining centre – Pořízení 5-osého CNC centra
Poland – Miscellaneous medical devices and products – Zakup i dostawa sprzętu i wyposażenia dla Zakładu Opiekuńczo-Leczniczego
Sweden – Water plumbing work – Ramavtal för entreprenader för schaktfri ledningsrenovering med flexibla foder
Poland – Miscellaneous evaluation or testing instruments – Zakup i dostawa do laboratoriów GIOŚ wyposażenia do zatężania ekstraktów chromatograficznych
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications